Donanemab in Early Alzheimer’s Disease
Original Article
M.A. Mintun, A.C. Lo, C.D. Evans, A.M. Wessels, P.A. Ardayfio, S.W. Andersen, S. Shcherbinin, J. Sparks, J.R. Sims, M. Brys, L.G. Apostolova, S.P. Salloway, and D.M. Skovronsky
N Engl J Med 2021;384:1691-1704
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
05/05/2021
Course expires:
05/06/2023
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, May 6, 2023 - 11:59pm.

Facebook
X
LinkedIn
Forward